Brief: Clearside Biomedical Announces Plan To Explore Strategic Alternatives To Advance Its Proprietary Suprachoroidal Space (Scs®) Delivery Platform And Promising Ophthalmology Pipeline
17/07/2025 12:59
Clearside Biomedical Inc CLSD.O: CLEARSIDE BIOMEDICAL ANNOUNCES PLAN TO EXPLORE STRATEGIC ALTERNATIVES TO ADVANCE ITS PROPRIETARY SUPRACHOROIDAL SPACE (SCS®) DELIVERY PLATFORM AND PROMISING OPHTHALMOLOGY PIPELINE CLEARSIDE BIOMEDICAL INC: ALTERNATIVES COULD INCLUDE SALE, LICENSE, MONETIZATION, DIVESTITURE OF ONE OR MORE OF ASSETS, AMONG OTHERS Source text: ID:nGNXbTT6wm Further company coverage: CLSD.O
Recent news on Clearside Biomedical,
See all newsBrief: Clearside Biomedical Completes Financial Restructuring And Emerges From Chapter 11 With Steel Partners As Plan Sponsor
U.S. STOCKS ON THE MOVE-Merck, Genco, Tesla
U.S. STOCKS ON THE MOVE-Morgan Stanley, Merck, Genco
Clearside Biomedical plunges after filing for Chapter 11 bankruptcy
U.S. STOCKS ON THE MOVE-Bristol Myers Squibb, Palo Alto Networks, MP Materials